Funding · Company
ALZHEON, INC.
Framingham, MABiotech & Pharma
ALZHEON, INC. of Framingham, MA has disclosed $205M across 2 Form D offerings filed with the SEC between Feb 10, 2025 and Sep 10, 2026.
$205M
Total disclosed
2
Form D offerings
5
Open roles today
Hiring — 5 open roles as of Nov 6, 2026
Counted from the company's own public job board.
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$79M
Form D · Sep 10, 2026 ↗
Q3 2026
· target $500M
$126M
Form D · Feb 10, 2025 ↗
Q1 2025
· 2 amendments, first filed Mar 12, 2024
· target $150M
Filing details
HeadquartersFramingham, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001582636Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →